[Endoscopic sclerotization of the oesophagus wall or transhepatic thrombosis of the coronary vein: Alternative or complementary therapy of bleeding oesophageal varices in portal hypertension (author's transl)].
Endoscopic sclerotization of esophageal wall has been performed in 48 patients with bleeding of esophageal varices. The mortality rate in the acute bleeding was 29,2%. There was no mortality, if sclerotherapy was done in the non hemorrhagic interval. Of the 48 patients 25 are still alive, 8 more than 2 years without bleeding. In 12 cases we performed transhepatic obliteration of the V. coronaria ventriculi. Only in 3 of them no further hemorrhage occurred within 6 months. Fibrosclerotization seems to be superior to the transhepatic obliteration, because the primary mortality and complications are lower and long term results better.
D003331:Coronary Vessels; D004621:Embolization, Therapeutic / Q000009:adverse effects; D004932:Esophageal and Gastric Varices / Q000209:etiology / Q000628:therapy*; D006491:Hemothorax / Q000209:etiology; D006801:Humans; D006975:Hypertension, Portal / Q000150:complications; D010996:Pleural Effusion / Q000209:etiology; D011169:Portal Vein; D012597:Sclerosing Solutions / Q000627:therapeutic use*; D013927:Thrombosis / Q000209:etiology
D012597:Sclerosing Solutions
Osophaguswandsklerosierung und transhepatische Verödung Alternative oder ergänzende Massnahmen zur Therapie der Osophagusvarizenblutung bei portaler Hypertension.